canventol has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiki, H; Komori, A; Okabe, S; Suganuma, M; Tius, MA; Zou, X | 1 |
| Busch-Petersen, J; Fujiki, H; Kannangara, GS; Kerr, MA; Komori, A; Oh, LM; Okabe, S; Suganuma, M; Tius, MA; Zhuo, J; Zou, X | 1 |
2 other study(ies) available for canventol and Skin Neoplasms
| Article | Year |
|---|---|
Canventol inhibits tumor promotion in CD-1 mouse skin through inhibition of tumor necrosis factor alpha release and of protein isoprenylation.
Topics: 3T3 Cells; 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Cyclohexanols; Diterpenes; Ethers, Cyclic; Female; Mevalonic Acid; Mice; Okadaic Acid; Protein Prenylation; Skin Neoplasms; Tumor Necrosis Factor-alpha | 1993 |
Anti-tumor promoting activity of canventol and its synthetic analogs through inhibition of protein isoprenylation.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Anticarcinogenic Agents; Carcinogens; Cyclohexanols; Enzyme Inhibitors; Female; Lipid Metabolism; Mevalonic Acid; Mice; Mice, Inbred Strains; Okadaic Acid; Protein Prenylation; Skin Neoplasms; Sterols; Transferases; Ubiquinone | 1996 |